## FDS: FactSet Research Systems Inc. - XLF: Financial Services

### Executive Summary

No thesis match: MRS_20 3.6% below STRENGTH zone (4.0-10.0%); PEG 1.68 fails VALUE criteria (<1.0). Stock is in no-man's land without clear edge.

- **Horizon:** N/A - no position
- **Risk Profile:** N/A - avoiding
- **Stop Type:** Fixed 2xATR ($275.13)
- **If Wrong:** N/A - wait for clearer setup
- **Invalidation:** MRS_20 falling below -5% or breaking key support

### News

- **Articles:** 10
- **Sentiment:** Neutral (Bullish: 1, Bearish: 2)

**1. FDS: Wells Fargo Lowers Price Target for FactSet Research Systems | FDS Stock News**
- Source: GuruFocus | 20251205T163628 | Bearish | Relevance: 100%
- Wells Fargo analyst Jason Haas has maintained an "Underweight" rating on FactSet Research Systems (FDS) and lowered its price target by 12.16% to $260. Previously, UBS upgraded FDS to "Buy" but lowered its price target, while other analysts from Wells Fargo, Barclays, Stifel, and Evercore ISI Group also adjusted their price targets downwards in September 2025. Despite these adjustments, the average target price from 16 analysts suggests an 18.84% upside from the current price, and GuruFocus estimates an 83.25% upside to its fair value.

**2. Is FactSet Now Attractive After AI Expansion and a 42% Share Price Slide?**
- Source: Sahm | 20251203T210910 | Somewhat-Bullish | Relevance: 100%
- FactSet Research Systems (FDS) has seen its share price drop by 42% over the past year, attracting valuation-focused investors despite recent AI expansion efforts. An Excess Returns analysis suggests FDS is undervalued by 17% at approximately $335 per share, while a Price-to-Earnings ratio comparison reveals the stock trading below industry averages but above its proprietary Fair Ratio, indicating it could be overvalued on that metric. The article encourages investors to consider different valuation narratives, from bullish scenarios involving AI integration to more cautious views factoring in competitive pressures.

**3. FactSet (NYSE: FDS) CLO has 731 shares withheld for RSU tax obligations**
- Source: Stock Titan | 20251203T162600 | Neutral | Relevance: 100%
- FactSet's Chief Legal Officer, Christopher McLoughlin, reported a routine share withholding of 731 shares to cover tax obligations arising from vested restricted stock units (RSUs). These shares were valued at $278.28 each, and the transaction occurred on December 2, 2025. Following this, McLoughlin beneficially owns 2,714.62 shares of FactSet common stock directly.

**4. Russell Investments Group Ltd. Cuts Stock Position in FactSet Research Systems Inc. $FDS**
- Source: MarketBeat | 20251203T111218 | Somewhat-Bearish | Relevance: 100%
- Russell Investments Group Ltd. reduced its stake in FactSet Research Systems Inc. by 23.8% in Q2, while institutional investors still hold a significant portion of the stock. Company insiders, however, increased their positions. FactSet recently released Q results showing an EPS miss but a revenue beat, announced a quarterly dividend, and holds a "Reduce" consensus analyst rating.

**5. FDS: Wells Fargo Lowers Price Target for FactSet Research Systems | FDS Stock News**
- Source: GuruFocus | 20251205T200957 | Bearish | Relevance: 100%
- Wells Fargo analyst Jason Haas has maintained an "Underweight" rating for FactSet Research Systems (FDS), while reducing the price target from $296.00 to $260.00 USD. This adjustment, a 12.16% decrease, follows a series of recent analyst downgrades and price target reductions for FDS, including those from UBS, Barclays, Stifel, and Evercore ISI Group. Despite these adjustments, the average one-year target price from 16 analysts is $340.46, implying an 18.84% upside from its current price, and the consensus brokerage recommendation is "Hold."

### Analyst Activity

**Target Signal:** BEARISH (Raises: 0, Lowers: 1)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-12-05 | Wells Fargo | $260 | $296 | -12% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-12-05 | Wells Fargo | main | Underweight |

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **MIXED** |
| Buys | 14 ($0.23M) |
| Sells | 8 ($0.24M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 58.0% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 5 / 5 |

**Top Holders:**
- Vanguard Group Inc: 13.2% (+2.2%)
- Blackrock Inc.: 9.1% (+1.2%)
- Ninety One UK Ltd: 6.5% (+102.4%)
- Morgan Stanley: 5.8% (-8.7%)
- State Street Corpora: 5.2% (+1.2%)

### Key Risks

1. Long-term trend broken: trading 24.2% below SMA200.
2. Market regime shift could impact momentum names disproportionately.
3. Sector rotation risk if leadership changes from current market theme.

### Catalysts

- AI/machine learning initiatives could drive multiple expansion if executed.
- Momentum building: MRS_20 improving +2.0% over 5 days suggests accumulation.

### Fundamentals

PEG ratio 1.68 elevated, pricing in significant growth expectations. Quality metrics strong (ROE 29%, ROA 11%, margin 25%). Analyst sentiment negative (1 target cuts vs 0 raises). Institutional flow bullish (5 buying vs 5 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $11.0B |
| Beta | 0.74 |
| 52W Range | $250.50 - $493.00 |
| Short Interest | 5.5% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 1.68 |
| Forward P/E | 15.3 |
| Current P/E | 16.6 |
| YoY Growth | 8.6% |
| EPS Direction | STABLE |

### Technicals

MRS_20 strengthening from 1.7% to 3.6% (+2.0% in 5 days), confirming momentum buildup. Below STRENGTH zone by 0.4pp (needs >4.0% for momentum thesis). MRS_5 at 2.9% confirms short-term momentum alignment. AM_20 at 6.1% shows strong absolute momentum above own 20MA. Outperforming sector by 4.0pp, stock-specific strength. Below SMA200 (0.76x), long-term trend not supportive. MACD histogram positive (2.35), confirming momentum. OFD pattern: +FTH (Rally).

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_20 | 3.65% (CS: 78) | Neutral |
| RSI_14 | 62.9 | Neutral |
| MACD Histogram | 2.35 | Bullish |
| vs SMA20 | 1.058x | Above |
| vs SMA50 | 1.045x | Above |
| vs SMA200 | 0.758x | Below |

### Decision

- **Verdict:** AVOID
- **Thesis:** NEUTRAL

### Trade Setup

- **Entry:** $290.63
- **Stop Loss:** $275.13 (5.3% risk)
- **Target:** $306.13 (R:R method)
- **Risk/Reward:** 1.00:1
- **Target Reasoning:** NEUTRAL thesis targets 1.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 64
- **Position Value:** $18,600.32
- **Portfolio %:** 18.60%
- **Risk Dollars:** $1,000.00
- **Risk Per Trade:** 1.00%
- **Modifiers:** L1 100% | L2 100% | Combined 1.00x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.00x |
| L2 Sector | NEUTRAL (Zone E) | 1.00x |

*NORMAL regime with balanced risk appetite. VIX near 15th percentile of 52-week range signals calm conditions, while modest yield curve steepening (54bps 10Y-3M) suggests healthy growth expectations. Breadth at 52% indicates selective participation rather than broad-based momentum.*

### Earnings

**Next:** 2025-12-18 (Est: $4.35)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q4 | $4.36 | $4.51 | +3.5% |
| 2025Q3 | $4.13 | $4.05 | -1.9% |
| 2025Q2 | $4.30 | $4.27 | -0.6% |
| 2025Q1 | $4.18 | $4.28 | +2.4% |

---
*RULE-based L3 | 2026-01-06 16:37 | MRS_20*